Research on psychedelic medicine would benefit from NIH funding - STAT
First-Of-Its-Kind Clinical Trial To Study Psychedelic Treatments For PTSD In Veterans
Clinical Study Shows Hallucinogenic Magic Mushroom Compound Psilocybin Relieves Depression
Psychedelic Treatment with Psilocybin Relieves Major Depression, Study Shows
Prohibition Partners on Twitter: "Psilocybin trials are ongoing, attempting to understand the impact the compound could have on treating the likes of depression, anxiety, OCD, Anorexia and Alzheimers. Download PSYCH: The Psychedelics
Psilocybin clinical trial confirms safety of group psychedelic sessions
More Psychedelic Studies Than Ever in 2021 | Defiance ETFs
Johns Hopkins Scientists Give Psychedelics the Serious Treatment - Scientific American
Magic mushroom medicine passes first clinical safety trial | Financial Times
Magic Mushrooms May Be the Biggest Advance in Treating Depression Since Prozac
Cybin Granted IRB Approval for Phase II Clinical Trials of its Sublingual Psilocybin Formulation for the Treatment of Major Depressive Disorder | Business Wire
Treatment-resistant depression (TRD)
Psychedelic therapy: Psilocybin shows promise as depression treatment in largest trial yet | New Scientist
Psilocybin Revisited: The Science Behind the Drug and Its Surprising Therapeutic Potential
Psirenity granted approval to conduct Jamaica's first
Psilocybin for Depression Study | The Beckley FoundationThe Beckley Foundation
How ecstasy and psilocybin are shaking up psychiatry
Braxia Scientific Corp. hits milestone as landmark psilocybin clinical trial begins with participants receiving first doses
Magic mushroom medicine passes first clinical safety trial | Financial Times
Braxia Scientific Achieves Milestone as Landmark Psilocybin Clinical Trial Commences, Participants Receive First Doses of Psilocybin
Psychedelic Research Timeline | The Beckley FoundationThe Beckley Foundation
Clinical Trial Finds Substantial Antidepressant Effects From Psilocybin-Assisted Therapy
Psychedelic Research Timeline | The Beckley FoundationThe Beckley Foundation
One dose of psilocybin improved neural connections lost in depression, study says – The Hill
Hopkins launches clinical trial for psilocybin mushrooms - The Johns Hopkins News-Letter
The renaissance of psilocybin as a viable treatment option - Pharmaceutical Technology
